Status:
COMPLETED
Long-term Follow-up of HALT-C Sustained Virological Responders
Lead Sponsor:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions:
Hepatitis C
Hepatocellular Carcinoma
Eligibility:
All Genders
18+ years
Brief Summary
The Hepatitis C Antiviral Long-term Treatment against Cirrhosis (HALT-C) trial is a multicenter clinical trial conducted to assess the effects of long-term antiviral drug therapy on the progression of...
Detailed Description
Subjects who have achieved a sustained virologic response during their participation in the multicentered HALT-C clinical trial for treatment of chronic hepatitis C are being invited to return for a s...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Patients who developed a virological response at week 20 of the HALT-C study.
- EXCLUSION CRITERIA:
- None
Exclusion
Key Trial Info
Start Date :
January 15 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 29 2012
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT00825877
Start Date
January 15 2009
End Date
June 29 2012
Last Update
December 17 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States, 20892